Meningitis B (University of Oxford)

N/A

Report date: 2024/07/25 17:11:40

Base Information

Drug NameMeningitis B (University of Oxford)
Drug Alias NameChAdOx1 MenB.1 (University of Oxford)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Oxford
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Oxford
Inactive CompaniesN/A
Active IndicationsMeningococcal InfectionsMeningitis, Meningococcal
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A